BioSpace News Archive

ICON plc (NASDAQ:ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the fourth quarter and full year ended December 31, 2021.

Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2022, which ended January 28, 2022 .

The healthcare CMO market has been projected to grow at a significant speed in the forthcoming years.

Fact.MR – A Market research and competitive intelligence provider: The stroke post-processing software market concludes that the industry is expected to flourish the market size at a CAGR of 8.9% from 2022 to 2032, and the industry is likely to experience a Y-o-Y expansion rate of 26% of the market share in 2022, reaching market valuation US$ 178 Mn.

Atrial flutter refers to abnormal rhythm of heart. It is marked with atrial rates of around 240 to 400 beats every minute and blockage in the node of atrioventricular.

Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential propellants to treat asthma and chronic obstructive pulmonary disease.

Cumulus Oncology, Europe’s first oncology biotech creation company, has secured a £4.1 million investment led by St Andrews-based investment firm Eos Advisory.

111, Inc. today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021 , before the U.S. market opens on Thursday, March 17, 2022.

Immunovia will participate in the Cowen 42nd Annual Health Care Virtual Conference on March 9, 2022.

RosVivo Therapeutics, Inc. announced that it has signed a Material Transfer Agreement with one of the largest global pharmaceutical companies Eli Lilly and Company for commercial development of diabetes and obesity treatments.